-
Je něco špatně v tomto záznamu ?
Alzheimer's Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis
T. Olejar, N. Jankovska, R. Matej
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
00064165
Ministry of Health, Czech Reoublic (Conceptual development of research organization)
00064190
Ministry of Health, Czech Reoublic (Conceptual development of research organization)
NU23-04-00173
Grants Agency of the Ministry of Health
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
39273636
DOI
10.3390/ijms25179689
Knihovny.cz E-zdroje
- MeSH
- Alzheimerova nemoc * metabolismus patologie etiologie MeSH
- amyloidní beta-protein * metabolismus MeSH
- buněčná membrána metabolismus MeSH
- fosforylace MeSH
- lidé MeSH
- peptidové fragmenty metabolismus MeSH
- protein 1 související s LDL-receptory * metabolismus MeSH
- proteiny tau * metabolismus MeSH
- tauopatie * metabolismus patologie etiologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The amyloid cascade hypothesis postulates that extracellular deposits of amyloid β (Aβ) are the primary and initial cause leading to the full development of Alzheimer's disease (AD) with intracellular neurofibrillary tangles; however, the details of this mechanism have not been fully described until now. Our preliminary data, coming from our day-to-day neuropathology practice, show that the primary location of the hyperphosphorylated tau protein is in the vicinity of the cell membrane of dystrophic neurites. This observation inspired us to formulate a hypothesis that presumes an interaction between low-density lipoprotein receptor-related protein 1 (LRP1) and fibrillar aggregates of, particularly, Aβ42 anchored at the periphery of neuritic plaques, making internalization of the LRP1-Aβ42 complex infeasible and, thus, causing membrane dysfunction, leading to the tauopathy characterized by intracellular accumulation and hyperphosphorylation of the tau protein. Understanding AD as a membrane dysfunction tauopathy may draw attention to new treatment approaches not only targeting Aβ42 production but also, perhaps paradoxically, preventing the formation of LRP1-Aβ42.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018967
- 003
- CZ-PrNML
- 005
- 20241024111210.0
- 007
- ta
- 008
- 241015s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms25179689 $2 doi
- 035 __
- $a (PubMed)39273636
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Olejar, Tomas $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic $1 https://orcid.org/0000000207865029 $7 xx0242541
- 245 10
- $a Alzheimer's Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis / $c T. Olejar, N. Jankovska, R. Matej
- 520 9_
- $a The amyloid cascade hypothesis postulates that extracellular deposits of amyloid β (Aβ) are the primary and initial cause leading to the full development of Alzheimer's disease (AD) with intracellular neurofibrillary tangles; however, the details of this mechanism have not been fully described until now. Our preliminary data, coming from our day-to-day neuropathology practice, show that the primary location of the hyperphosphorylated tau protein is in the vicinity of the cell membrane of dystrophic neurites. This observation inspired us to formulate a hypothesis that presumes an interaction between low-density lipoprotein receptor-related protein 1 (LRP1) and fibrillar aggregates of, particularly, Aβ42 anchored at the periphery of neuritic plaques, making internalization of the LRP1-Aβ42 complex infeasible and, thus, causing membrane dysfunction, leading to the tauopathy characterized by intracellular accumulation and hyperphosphorylation of the tau protein. Understanding AD as a membrane dysfunction tauopathy may draw attention to new treatment approaches not only targeting Aβ42 production but also, perhaps paradoxically, preventing the formation of LRP1-Aβ42.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Alzheimerova nemoc $x metabolismus $x patologie $x etiologie $7 D000544
- 650 12
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 12
- $a proteiny tau $x metabolismus $7 D016875
- 650 12
- $a protein 1 související s LDL-receptory $x metabolismus $7 D026503
- 650 12
- $a tauopatie $x metabolismus $x patologie $x etiologie $7 D024801
- 650 _2
- $a buněčná membrána $x metabolismus $7 D002462
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a peptidové fragmenty $x metabolismus $7 D010446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Jankovska, Nikol $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic $1 https://orcid.org/0000000184222628
- 700 1_
- $a Matej, Radoslav $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic $u Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, 128 00 Prague, Czech Republic $1 https://orcid.org/0000000261526343
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 25, č. 17 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39273636 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111204 $b ABA008
- 999 __
- $a ok $b bmc $g 2201669 $s 1230940
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 25 $c 17 $e 20240907 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a 00064165 $p Ministry of Health, Czech Reoublic (Conceptual development of research organization)
- GRA __
- $a 00064190 $p Ministry of Health, Czech Reoublic (Conceptual development of research organization)
- GRA __
- $a NU23-04-00173 $p Grants Agency of the Ministry of Health
- LZP __
- $a Pubmed-20241015